Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
84.69
+0.47 (0.56%)
At close: Jul 25, 2025, 4:00 PM
84.22
-0.47 (-0.55%)
After-hours: Jul 25, 2025, 5:42 PM EDT
Merit Medical Systems Stock Forecast
Stock Price Forecast
The 9 analysts that cover Merit Medical Systems stock have a consensus rating of "Buy" and an average price target of $109.11, which forecasts a 28.83% increase in the stock price over the next year. The lowest target is $103 and the highest is $120.
Price Target: $109.11 (+28.83%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Merit Medical Systems stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $108 | Strong Buy | Reiterates | $108 | +27.52% | Jul 18, 2025 |
| Needham | Needham | Strong Buy Reiterates $108 | Strong Buy | Reiterates | $108 | +27.52% | Jul 8, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $106 → $110 | Buy | Maintains | $106 → $110 | +29.89% | May 23, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $108 → $112 | Strong Buy | Maintains | $108 → $112 | +32.25% | May 21, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $106 → $108 | Buy | Maintains | $106 → $108 | +27.52% | May 21, 2025 |
Financial Forecast
Revenue This Year
1.52B
from 1.36B
Increased by 11.83%
Revenue Next Year
1.61B
from 1.52B
Increased by 6.26%
EPS This Year
3.41
from 2.03
Increased by 68.19%
EPS Next Year
3.86
from 3.41
Increased by 13.20%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.6B | 1.7B | 1.8B | ||
| Avg | 1.5B | 1.6B | 1.7B | ||
| Low | 1.4B | 1.5B | 1.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 16.0% | 11.1% | 11.6% | ||
| Avg | 11.8% | 6.3% | 6.1% | ||
| Low | 6.8% | 0.2% | -1.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.56 | 4.20 | 4.39 | ||
| Avg | 3.41 | 3.86 | 4.18 | ||
| Low | 3.24 | 3.53 | 3.90 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 75.3% | 23.0% | 13.6% | ||
| Avg | 68.2% | 13.2% | 8.2% | ||
| Low | 59.8% | 3.4% | 0.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.